Canakinumab injection for the treatment of active Still’s disease, including adult-onset Still’s disease

Still’s disease is a systemic, non-monogenic autoinflammatory condition affecting both children and adolescents (systemic juvenile idiopathic arthritis, sJIA) and adults (adult-onset Still’s diseas...